Literature DB >> 26681496

Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience.

Michael Loureiro1, Cecilia Kramar2, Justine Renard2, Laura G Rosen2, Steven R Laviolette3.   

Abstract

BACKGROUND: Cannabinoid receptor transmission strongly influences emotional processing, and disturbances in cannabinoid signaling are associated with various neuropsychiatric disorders. The mammalian ventral hippocampus (vHipp) is a critical neural region controlling mesolimbic activity via glutamatergic projections to the nucleus accumbens. Furthermore, vHipp abnormalities are linked to schizophrenia-related psychopathology. Nevertheless, the mechanisms by which intra-vHipp cannabinoid signaling may modulate mesolimbic activity states and emotional processing are not currently understood.
METHODS: Using an integrative combination of in vivo electrophysiological recordings and behavioral pharmacologic assays in rats, we tested whether activation of cannabinoid type 1 receptors (CB1R) in the vHipp may modulate neuronal activity in the shell subregion of the nucleus accumbens (NASh). We next examined how vHipp CB1R signaling may control the salience of rewarding or aversive emotional memory formation and social interaction/recognition behaviors via intra-NASh glutamatergic transmission.
RESULTS: We demonstrate for the first time that vHipp CB1R transmission can potently modulate NASh neuronal activity and can differentially control the formation of context-dependent and context-independent forms of rewarding or aversion-related emotional associative memories. In addition, we found that activation of vHipp CB1R transmission strongly disrupts normal social behavior and cognition. Finally, we report that these behavioral effects are dependent upon intra-NASh alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid/N-methyl-D-aspartate receptor transmission.
CONCLUSIONS: Together, these findings demonstrate a critical role for hippocampal cannabinoid signaling in the modulation of mesolimbic neuronal activity states and suggest that dysregulation of CB1R transmission in the vHipp→NASh circuit may underlie hippocampal-mediated affective and social behavioral disturbances present in neuropsychiatric disorders.
Copyright © 2016 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; CB(1) receptor; Glutamate; Morphine; Schizophrenia; Ventral hippocampus

Mesh:

Substances:

Year:  2015        PMID: 26681496     DOI: 10.1016/j.biopsych.2015.10.016

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  15 in total

1.  Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.

Authors:  Roger Hudson; Justine Renard; Christopher Norris; Walter J Rushlow; Steven R Laviolette
Journal:  J Neurosci       Date:  2019-09-30       Impact factor: 6.167

Review 2.  μ opioid receptor, social behaviour and autism spectrum disorder: reward matters.

Authors:  Lucie P Pellissier; Jorge Gandía; Thibaut Laboute; Jérôme A J Becker; Julie Le Merrer
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

Review 3.  Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology.

Authors:  Roger Hudson; Walter Rushlow; Steven R Laviolette
Journal:  Psychopharmacology (Berl)       Date:  2017-10-24       Impact factor: 4.530

Review 4.  Combinatorial approaches for treating neuropsychiatric social impairment.

Authors:  Don Wei; Sherab Tsheringla; James C McPartland; A Z A Stephen Azariah Allsop
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2022-07-11       Impact factor: 6.671

Review 5.  Anxiety and hippocampal neuronal activity: Relationship and potential mechanisms.

Authors:  Maedeh Ghasemi; Mojdeh Navidhamidi; Fatemeh Rezaei; Armin Azizikia; Nasrin Mehranfard
Journal:  Cogn Affect Behav Neurosci       Date:  2021-12-06       Impact factor: 3.526

6.  Chemokine receptor CCR2 contributes to neuropathic pain and the associated depression via increasing NR2B-mediated currents in both D1 and D2 dopamine receptor-containing medium spiny neurons in the nucleus accumbens shell.

Authors:  Xiao-Bo Wu; Peng-Bo Jing; Zhi-Jun Zhang; De-Li Cao; Ming-Hui Gao; Bao-Chun Jiang; Yong-Jing Gao
Journal:  Neuropsychopharmacology       Date:  2018-06-11       Impact factor: 7.853

7.  Differential Expression of FosB Proteins and Potential Target Genes in Select Brain Regions of Addiction and Depression Patients.

Authors:  Paula A Gajewski; Gustavo Turecki; Alfred J Robison
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

Review 8.  Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research.

Authors:  Rafael N Ruggiero; Matheus T Rossignoli; Jana B De Ross; Jaime E C Hallak; Joao P Leite; Lezio S Bueno-Junior
Journal:  Front Pharmacol       Date:  2017-06-21       Impact factor: 5.810

Review 9.  Molecular and neurocircuitry mechanisms of social avoidance.

Authors:  Anne-Kathrin Gellner; Jella Voelter; Ulrike Schmidt; Eva Carolina Beins; Valentin Stein; Alexandra Philipsen; René Hurlemann
Journal:  Cell Mol Life Sci       Date:  2020-09-30       Impact factor: 9.261

10.  Palmitoylethanolamide Modulates GPR55 Receptor Signaling in the Ventral Hippocampus to Regulate Mesolimbic Dopamine Activity, Social Interaction, and Memory Processing.

Authors:  Cecilia Kramar; Michael Loureiro; Justine Renard; Steven R Laviolette
Journal:  Cannabis Cannabinoid Res       Date:  2017-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.